Zacks Small Cap Research on MSN
YDES: YD Biopharma is an integrated biotechnology company that is poised to have a transformational year as it expands business operations.
YDES YD Bio (NASDAQ:YDES) is an integrated biotechnology company that combines diagnostics, precision medicine, and ...
High probability of technical success in pivotal Phase 3 trial based on unmatched efficacy data for third-line non-small cell ...
Brennen McKenzie, MA, MSc, VMD, director of veterinary medicine at Loyal, a biotechnology company focusing on extending the ...
A new artificial intelligence (AI) method called BioPathNet helps researchers systematically search large biological data ...
The landscape of next-generation sequencing (NGS) continues to be defined by astonishing technological progress. We continue ...
One of the most striking trends at PCHi will be the industry's intensified focus on fast and scientifically validated efficacy. Chinese consumers are becoming increasingly discerning, expecting ...
High probability of technical success in pivotal Phase 3 trial based on unmatched efficacy data for third-line non-small cell lung cancer (NSCLC) treatment FDA's Fast Track designation for ateganosine ...
Nzimande highlighted that South Africa hosts Africa’s largest public science system, anchored by globally recognised ...
Namodenoson is a highly selective A3 adenosine receptor (A3AR) agonist, which has shown a compelling safety profile and ...
bne IntelliNews on MSN
Poland’s M&A activity dips in 2025
Merger and acquisition activity in Poland declined in 2025, with 330 transactions completed over the year, a 5% decrease from ...
There are hundreds of cell types in the human body, each with a specific role spelled out in their DNA. In theory, all it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback